Cash & equivalents increased 22.5%
Cash & equivalents changed +22.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +22.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt changed -65.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed +121.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +71.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed -26037 basis points from the comparable as-filed period.
Research & development changed +48.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed -87.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Stock-based compensation changed +581.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.